The major goal of this research is to determine the degree to which mRNA stability is dependent upon tissue specific factors, the intrinsic nucleotide structure of the mRNA, and the flanking regions contained in the genomic sequence coding for the message. To approach these studies we will use DNA-mediated gene transfer techniques to introduce the bovine growth hormone (bGH) gene into a variety of cell types and then examine the stability of bGH mRNA transcripts made in these cells. Both pituitary and non-pituitary cells will be used as recipient cells for bGH gene transfer, including a stable cell-line of virally transformed bovine pituitary cells. The bGH gene is particularly well-suited for such studies since it codes for an unusually stable mRNA, its expression is regulated by both glucocorticoid and thyroid hormones and the GH gene is contained in a relatively small restriction fragment (2kb) which lacks apparent internal Pol III promoters. These studies should provide basic information on the role of mRNA stability in the regulation of gene expression. The availability of this transformation system will also allow us to study several other potentially important control mechanisms for regulating GH gene expression. We have described a highly conserved sequence of nucleotides in the 5'-flanking region of the bGH gene which is 38 nt in length and shows greater than 90% homology with similar regions of the rat and human GH genes. The function of this sequence, which could potentially be involved in hormonal regulation of this gene, will be examined by in vitro site-directed mutagenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK032770-05
Application #
3231124
Study Section
Biochemistry Study Section (BIO)
Project Start
1983-08-01
Project End
1988-07-31
Budget Start
1987-08-01
Budget End
1988-07-31
Support Year
5
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Li, X; Shambaugh, M E; Rottman, F M et al. (2000) SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro. RNA 6:1847-58
Dirksen, W P; Li, X; Mayeda, A et al. (2000) Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer. J Biol Chem 275:29170-7
Stallings-Mann, M L; Ludwiczak, R L; Klinger, K W et al. (1996) Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism. Proc Natl Acad Sci U S A 93:12394-9
Dirksen, W P; Sun, Q; Rottman, F M (1995) Multiple splicing signals control alternative intron retention of bovine growth hormone pre-mRNA. J Biol Chem 270:5346-52
Dirksen, W P; Hampson, R K; Sun, Q et al. (1994) A purine-rich exon sequence enhances alternative splicing of bovine growth hormone pre-mRNA. J Biol Chem 269:6431-6
Sun, Q; Hampson, R K; Rottman, F M (1993) In vitro analysis of bovine growth hormone pre-mRNA alternative splicing. Involvement of exon sequences and trans-acting factor(s). J Biol Chem 268:15659-66
Sun, Q; Mayeda, A; Hampson, R K et al. (1993) General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev 7:2598-608
Salata, R A; Malhotra, I J; Hampson, R K et al. (1992) Application of an immune-tolerizing procedure to generate monoclonal antibodies specific to an alternate protein isoform of bovine growth hormone. Anal Biochem 207:142-9
Goodwin, E C; Rottman, F M (1992) The 3'-flanking sequence of the bovine growth hormone gene contains novel elements required for efficient and accurate polyadenylation. J Biol Chem 267:16330-4
Helms, S R; Rottman, F M (1990) Characterization of an inducible promoter system to investigate decay of stable mRNA molecules. Nucleic Acids Res 18:255-9

Showing the most recent 10 out of 12 publications